Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Bone diseases

Risk prediction

04-10-2022 | Systemic sclerosis | News

Elevated risk for osteoporotic fractures in women with SSc

Findings from two studies suggest that more attention may need to be given to the prevention of osteoporotic fractures among women with systemic sclerosis.

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

Browse the hub

Anifrolumab for the treatment of lupus

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

Visit the hub

New additions to the Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Visit the hub

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

3–9 November: Keep up with the latest news and interviews from the conference.

Visit the conference hub

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Read the article

Telemedicine in rheumatology

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Browse the hub

Get ready for ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

Visit the conference hub

19-11-2018 | Osteoporosis | Article

Risk of subsequent fracture after prior fracture among older women

Balasubramanian A et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4732-1

Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis

This study aimed to examine the relationship between medication persistence and fracture risk among female Medicare beneficiaries diagnosed with osteoporosis [read more].
Liu J et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4630-6

Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis

28-07-2018 | Osteoarthritis | Review | Article

The impact of sarcopenic obesity on knee and hip osteoarthritis: A scoping review

Godziuk K et al. BMC Musculoskelet Disord 2018; 19: 271. doi: 10.1186/s12891-018-2175-7

23-07-2018 | Osteoporosis | Article

Incidence, risk factors, and fracture healing of atypical femoral fractures: A multicenter case-control study

Lim SJ et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4640-4

18-07-2018 | Osteoporosis | Article

Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis

Liu J et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4630-6

21-06-2018 | Osteoporosis | Article

Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys

Yoshimura N et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4596-4

02-05-2018 | Osteoporosis | Review | Article

Novel imaging modalities in osteoporosis diagnosis and risk stratification

Haque S et al. Curr Treat Options in Rheum 2018; Advance online publication. doi: 10.1007/s40674-018-0099-x

Gout as a risk factor for osteoporosis: Epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals

This first population-based epidemiologic study supports the hypothesis that compared with individuals without gout; those with gout have a modest increase in the risk of developing osteoporosis in future [read more].
Kok VC et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4375-2

Gout as a risk factor for osteoporosis: Epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals

04-08-2017 | Rheumatoid arthritis | Review | Article

Skeletal complications of rheumatoid arthritis

Heinlen & Humphrey review the clinical evidence for abnormal skeletal health in patients with rheumatoid arthritis and the effects of disease modifying anti-rheumatic drugs on bone health.

Heinlen L, Humphrey MB. Osteoporos Int 2017. doi:10.1007/s00198-017-4170-5

19-04-2017 | Osteoporosis | Review | Article

UK clinical guideline for the prevention and treatment of osteoporosis

This guideline, accredited by the National Institute of Health and Care Excellence, provides an overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.

Compston J, Cooper A, Cooper C et al. Arch Osteoporos 2017;12:43. doi:10.1007/s11657-017-0324-5

More


More on bone diseases


« Back to main page | Osteoporosis | Clinical trials | Diagnosis and screening | Epidemiology | Fracture | Lifestyle interventions | Medications | Pain | Pathophysiology | Prevention | Quality of life | Risk prediction


Image Credits